Etoricoxib

Product Description

Niksan Pharmaceutical is one of the leading manufacturer ,supplier and exporter of the Etoricoxib. The best product manufactured by Niksan Pharmaceutical is Etoricoxib.  We manufacture, supply and export best quality product of Etoricoxib API along with Etoricoxib formulations.

Niksan Pharmaceutical is also manufacture and export largequantity of Etoricoxib  products in whole globe since many years incountries like Costa Rica, Mexico, Guatemala, Honduras, Finland, Ecuador,Colombia, Nepal Philippines, Singapore, Panama, Argentina, Peru, Dominican Republic, Portugal, Chile, Kenya, Bangladesh, Hong Kong , United Arab Emirates,Germany, Latvia, El Salvador, Iraq, Paraguay, Estonia, Jordan, Sri Lanka, SouthAfrica, Malaysia, Ireland, Sweden, Netherlands, Norway, Vietnam, Lithuania,Thailand, Bolivia, Israel, Italy, Spain, Pakistan, Romania Indonesia,Venezuela, United Kingdom, Taiwan, Saudi Arabia, Greece, New Zealand,Switzerland, Egypt, Belgium, Poland , Australia, Brazil, France, Canada, United States, Russia, Turkey and many more countries.

Niksan Pharmaceutical provides best quality product of Etoricoxib in all states of India like Kerala, Punjab, Rajasthan, Telangana,Uttar Pradesh, Gujarat, Delhi, Tamil Nadu, Bihar, Karnataka, Jammu and Kashmir,Maharashtra, West Bengal, Odisha, Madhya Pradesh, Andhra Pradesh, Haryana  and many other states.

Etoricoxib is one type of non-steroidal anti-inflammatory drug. Etoricoxib used in to relief the pain and inflammation of the  body. It is COX-2 selective inhibitor drug which is used in the inflammation.

Etoricoxib mainly used in to inhibit the pain caused by gout, rheumatoid arthritis, acute prospective pain, back pain,osteoarthritis. 

SYNONYMS: Etoricoxib,Etoricoxibum.

IUPAC NAME:5-chloro-3-(4-methanesulfonylphenyl)-2-(6-methylpyridin-3-yl)pyridine

CAS NO: 202409-33-4 

FORMULA: C₁₈H₁₅ClN₂O₂S 

MOLECULAR MASS: 358.84 g/mol 

STORAGE CONDITION: Store in a room temperature away from direct heat and light. Keep away from children and pets. Do not put medication in bathroom or any humid place. 

HOW TO USE: Use Etoricoxib daily once with or without food. Take medicine orally as prescribed by your doctor, take you doctors advice if you have confusion regarding to the medicine.

HOW ETORICOXIB WORKS: Etoricoxib is the selective COX-2 inhibitor,it inhibits the COX-2 enzyme by this the production of prostaglandin is also inhibited and by this process it gives anti-inflammation effects to the body. 

PHARMACOKINETICS OF ETORICOXIB: Etoricoxib have 100% bioavaibility after oral administration. About 92% of the medicine binds with the blood plasma protein. Etoricoxib takes 1 hour to reach the peak plasma concentration.  The half-life of Etoricoxib is about 22 hours. Only 1% of the drug eliminated unchanged in  urine. The drug is eliminated by urination and also excreted in feces. 

SIDE EFFECTS OF ETORICOXIB: The common side effects of Etoricoxib are headache, nausea, feeling sick, vomiting, high blood pressure and dizziness. Tell your doctor if you feel chest pain, abdominal pain, stomach problem, heartburn, ingestion, swelling of legs and figures. 

PRECAUTIONS: Kindly stop taking the medication if you feel hypersensitivity towards the medicine. Etoricoxib also cause fever and other inflammation. Do workout after taking the medicine it can help you to prevent inflammation. Tell your doctor if you have past problems like liver problem,heart problem, liver problem. 

CDSCO APPROVAL: Thiocolchicoside 8 mg + Etoricoxib 60 mg tablets approved by CDSCO in India in 25.04.2009,

Etoricoxib tablets approved by CDSCO in India in March-2004,

Etoricoxib10mg + Methyl Salicylate 100mg + Menthol 50mg + Linseed oil  30mg per gm. of Gel  approved by CDSCO in India in  14.12.2006,

Etoricoxibroll on Topical Solution 1% v/v approved by CDSCO in India in 16.09.2008,

Etoricoxib+ Paracetamol (60mg + 500mg) Tablets approved by CDSCO in India in 30.09.2008

Thiocolchicoside+ Etoricoxib (4mg + 60 mg) FC Tablet approved by CDSCO in India in 17.11.2008,

Etoricoxib10mg + Methyl salicylate 20mg per gm. of cream approved by CDSCO in India in 21.03.2007,

Etoricoxib1%+ Menthol 5% Spray approved by CDSCO in India in 16.03.2010,

Etoricoxib injection 90mg/ml approved by CDSCO in India in 28.03.2008

FORMULATIONS AVAILABLE IN MARKET:

Etoricoxib60mg tablets

Etoricoxib90mg tablets

Etoricoxib90mg/ml solution

Etoricoxib10mg + Methyl Salicylate 100mg + Menthol 50mg + Linseed oil 30mg per gm. ofGel 

Thiocolchicoside4mg + Etoricoxib 60mg tablets

Etoricoxib10mg + Methyl salicylate 20mg creams

Etoricoxib1%+ Menthol 5% Spray

Note: Product protected by valid patents are not offered for sale in countries where such patents are still valid and its liability is at Buyers Risk

REFERENCES: 

www.webmd.com

https://pubchem.ncbi.nlm.nih.gov

https://go.drugbank.com

https://cdscoonline.gov.in

https://www.wikipedia.org/

https://www.drugs.com

https://www.zaubacorp.com

https://www.practo.com/consult